Authors: Will, BP Berthelot, JM Nobrega, KM Flanagan, W Evans, WK

Citation: Bp. Will et al., Canada's Population Health Model (POHEM): a tool for performing economic evaluations of cancer control interventions, EUR J CANC, 37(14), 2001, pp. 1797-1804

Authors: Will, BP Nobrega, KM Berthelot, JM Flanagan, W Wolfson, MC Logan, DM Evans, WK

Citation: Bp. Will et al., First do no harm: extending the debate on the provision of preventive tamoxifen, BR J CANC, 85(9), 2001, pp. 1280-1288

Authors: Berthelot, JM Will, BP Evans, WK Coyle, D Earle, CC Bordeleau, L

Citation: Jm. Berthelot et al., Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer, J NAT CANC, 92(16), 2000, pp. 1321-1329

Authors: Will, BP Berthelot, JM Le Petit, C Tomiak, EM Verma, S Evans, WK

Citation: Bp. Will et al., Estimates of the lifetime costs of breast cancer treatment in Canada, EUR J CANC, 36(6), 2000, pp. 724-735

Authors: Evans, WK Will, BP Berthelot, JM Logan, DM Mirsky, DJ Kelly, N

Citation: Wk. Evans et al., Breast cancer: Better care for less cost - Is it possible?, INT J TE A, 16(4), 2000, pp. 1168-1178

Authors: Will, BP Le Petit, C Berthelot, JM Tomiak, EM Verma, S Evans, WK

Citation: Bp. Will et al., Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs, BR J CANC, 79(9-10), 1999, pp. 1428-1436